Видео ютуба по тегу Exdensur

FDA Approves Exdensur: The First Twice Yearly Biologic for Severe Asthma Attacks
FDA Approves Exdensur: The First Twice Yearly Biologic for Severe Asthma Attacks
Five Things Must Know for Exdensur (Depemokimab)!
Five Things Must Know for Exdensur (Depemokimab)!
Тяжелая эозинофильная астма? Представляем EXDENSUR — новое средство лечения!
Тяжелая эозинофильная астма? Представляем EXDENSUR — новое средство лечения!
Страдаете от тяжелой формы астмы? Инъекция ЭКСДЕНСУР (депемокимаб-ула).
Страдаете от тяжелой формы астмы? Инъекция ЭКСДЕНСУР (депемокимаб-ула).
FDA Approves GSK's Exdensur: Twice-Yearly Shot Revolutionizes Severe Asthma Care
FDA Approves GSK's Exdensur: Twice-Yearly Shot Revolutionizes Severe Asthma Care
Exdensur: A Breakthrough Treatment for Asthma and Chronic Rhinosinusitis
Exdensur: A Breakthrough Treatment for Asthma and Chronic Rhinosinusitis
Exdensur (depemokimab): FDA Approval for Severe Asthma — What It Means
Exdensur (depemokimab): FDA Approval for Severe Asthma — What It Means
GSK Exdensur Approval and Biologic Market Dynamics
GSK Exdensur Approval and Biologic Market Dynamics
FDA Approved Asthma Injection Explained | Exdensur (depemokimab-ulaa) | Pharmacist Review
FDA Approved Asthma Injection Explained | Exdensur (depemokimab-ulaa) | Pharmacist Review
New Breakthrough Asthma Drug (depemokimab) Explained
New Breakthrough Asthma Drug (depemokimab) Explained
GSK's New Asthma Drug: A Game-Changer for Patients
GSK's New Asthma Drug: A Game-Changer for Patients
Одобрение препарата Exdensur Depemokimab в Великобритании: прорыв в лечении астмы и полипов носа.
Одобрение препарата Exdensur Depemokimab в Великобритании: прорыв в лечении астмы и полипов носа.
FDA Approves Exdensur for Severe Asthma: New Biologic Treatment Explained
FDA Approves Exdensur for Severe Asthma: New Biologic Treatment Explained
В Великобритании одобрен биологический препарат для лечения астмы и хронического риносинусита с п...
В Великобритании одобрен биологический препарат для лечения астмы и хронического риносинусита с п...
EXDENSUR (depemokimab) Approved as an Injectable Ultra-Long-Acting Therapy for Severe Asthma
EXDENSUR (depemokimab) Approved as an Injectable Ultra-Long-Acting Therapy for Severe Asthma
This New Asthma Treatment Only Needs 2 Doses Per Year? (Dipimokimab)
This New Asthma Treatment Only Needs 2 Doses Per Year? (Dipimokimab)
Exdensur El noticiero de Así paso en el mundo.
Exdensur El noticiero de Así paso en el mundo.
تم التحقق..
تم التحقق.. "ستوديو إكسترا" يوضح حقيقة ظهور علاج يشفي من "الفيبروميالجيا"
Severe Asthma Patients Finally Get Relief — Just 2 Injections a Year
Severe Asthma Patients Finally Get Relief — Just 2 Injections a Year
Drugs.com - Monthly Update December 2025
Drugs.com - Monthly Update December 2025